Unichem Pharmaceuticals USA Inc. is recalling 230 bottles of Cyclobenzaprine Hydrochloride Tablets (10 mg) because some bottles may actually contain Meloxicam (7.5 mg). Cyclobenzaprine is a muscle relaxant that is typically a blue tablet, but the mislabeled bottles may contain yellow Meloxicam tablets, which is a non-steroidal anti-inflammatory drug (NSAID). No incidents or injuries have been reported to date, but this mix-up could lead to consumers taking the wrong medication.
Taking Meloxicam when expecting Cyclobenzaprine can lead to unintended NSAID exposure, which may cause serious risks including gastrointestinal bleeding, kidney issues, or allergic reactions, especially in patients already taking other NSAIDs or with pre-existing conditions.
You have 2 options:
Mislabeled; bottles may contain yellow Meloxicam USP 7.5mg tablets instead of blue Cyclobenzaprine tablets.
Cyclobenzaprine Hydrochloride Tablets, USP 10 mg package front”
“Inside package label”
Meloxicam 7.5mg Tablet
Cyclobenzaprine HCl, 10mg Tablet
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.